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ABSTRACT
PURPOSE: The failure of small-caliber vascular grafts still means a serious problem. Concerning the early postoperative complications 
we aimed to investigate the hemostaseological and hemorheological aspects of this issue in a canine model.
METHODS: In the Control group only anesthesia was induced. In the Grafted group under general anesthesia a 3.5-cm segment was 
resected unilaterally from the femoral artery and replaced with a PTFE graft (diameter: 3 mm). On the 1st-3rd-5th-7th and 14th postoperative 
days the skin temperature of both hind limbs was measured, and blood sampling occurred for hematological, hemostaseological and 
hemorheological tests.
RESULTS: The skin temperature of the operated versus intact limbs did not differ. In the Grafted group leukocyte count was elevated 
by the 1st postoperative day, while platelet count increased over the entire follow-up period. Fibrinogen concentration rose on the 1st-5th 
days, activated partial thromboplastin time increased on the 3rd-7th days. Erythrocyte aggregation was enhanced significantly on the 1st-
5th days. In specimens taken on the 14th day, histologically we found matured thrombus narrowing the graft lumen.
CONCLUSIONS: Small-caliber PTFE graft implantation into the femoral artery caused significant changes in several hemostaseological 
and hemorheological parameters. However, better clarifying the factors leading to early thrombosis of these grafts needs further studies.
Key words: Vascular Grafting. Graft Occlusion, Vascular.  Erythrocyte Aggregation. Blood Coagulation. Models, Animal. Dogs.
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Introduction
Open surgical procedures, such as bypass operations 
still have an important role in today’s vascular surgery1-5. For 
the bypass implants, the patient’s superficial vein or artificial 
vascular graft is used, what can be made of polyethylene 
terephthalate (PTE, Dacron®) or polytetrafluoroethylene 
(PTFE). However, bypass surgeries made with the patients’ 
own veins are statistically proved to have twice as more patency 
rates than the artificial grafts6-8.
During the last 10-15 years a reduction in the number of 
infrainguinal bypass operations can be observed4,5. The reasons 
are not well known but risk factor reduction, modification, 
early referral and the improvement of the endovascular 
techniques (even for TASC C,D lesions) could be a reason for 
that. However, by surgeons’ opinion the open surgery remains 
the first choice for TASC D lesions4-6. The greater saphenous 
vein (GSV) is the gold standard for infrainguinal bypasses at 
any level. If the GSV is of poor quality or has been removed 
(for example CABG or varicectomy was performed), the use 
of the contralateral GSV has to be considered, rather than arm 
veins, which have lower patency rates. In case of the surgeries 
above the knee the implantation of an artificial graft is chosen 
since with progression of the underlying disease it might be 
the necessary to do surgery below the knee, where veins are 
preferred for the bypass4-6.
In absence of vein a prosthetic graft should be used. 
In this case a vein cuff recommended at the distal anastomosis. 
The Joint Vascular Research Group RCT of Miller vein cuff 
versus non-cuff for femoro-distal PTFE grafts demonstrated 
significantly higher patency rates for prosthetic graft with vein 
segment at P III level. The number of prosthetic grafts, used for 
intermittent claudication/critical limb ischemia has fallen. Poor 
patency rate and the concerns about graft infections are the main 
reasons for that1-5,9-13.
The first couple of postoperative days are always 
critical. The problem of early thrombosis in case of small-
diameter artificial vascular conduits still means a serious 
question in vascular surgery9. The wall of the artificial graft is 
more rigid, the arterial three-phased blood flow pattern cannot 
be observed. After the implantation of an artificial vascular graft, 
we may see several early and late complications. Early: suture 
insufficiency, hemorrhage, graft infection, wound infection, 
vascular and nerve injuries, early obstruction of the graft. 
Late: pseudoaneurysm formation due to suture insufficiency, 
obstruction of the graft, stenosis caused by neointima formation 
or occlusion, graft infection9-13. The blood flow characteristics 
change at the anastomoses, the cells may suffer mechanical 
injury - here the formation of deposits usually leads to another 
operation10,12-14. Although it is not completely clarified that 
from which point the flow properties of the altered vascular 
geometry can lead to thrombotic complications later.
The aim our study was to investigate the effect of the 
presence of unilaterally implanted PTFE graft into the femoral 
artery in a canine model, focusing on the early postoperative 
changes in general haematological parameters, red blood cell 
aggregation and general blood coagulation parameters.
Methods
The experiments were approved and registered by 
the University of Debrecen Committee of Animal Research 
(permission Nr.: 20/2011. UD CAR), in accordance with the 
relevant Hungarian Animal Protection Act (Law XVIII/1998) 
and EU directives.
All the surgical interventions were performed under 
general anesthesia (10 mg/kg ketamin + 0.1 mg/kg xylazin, i.m.)
In the Grafted group (n=5): the left femoral artery 
was gently exposed and atraumatically clamped proximally 
and distally. A 3.5 cm long segment was excised and replaced 
with a polytetrafluoroethylene (PTFE) graft (diameter = 3 mm, 
Atrium Co.) of the same length (3.52 ± 0.48 cm) using end-to-
end anastomoses (continuously suture line, 6/0 polypropylene). 
The time for the necessary clamping of the vessel was 25 ± 
3.1 minutes. In the Control group (n=4) only anesthesia was 
induced and for a 2-hour-period animals were laid on the 
operative table under the same circumstances as in the Grafted 
group.
Animals received 1000 IU sodium-heparin 
intravenously at the beginning of the operation. Postoperatively, 
on the 1st and 3rd days 500 IU Clexan was given subcutaneously. 
Intramuscularly 50 µg/kg sodium-metamizole (Algopyrin 1 
g/2 ml ampule) was administered for analgesia just after the 
operation and on the 1st postoperative day.
Via puncturing the cephalic vein, blood samples were 
collected before the operation, on the 1st, 3rd, 5th, 7th and on the 14th 
postoperative days using Vacutainer® system.
Laboratory tests
For testing hematological parameters we used a Sysmex 
F-800 microcell counter (TOA Medical Electronics Co. Ltd., 
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Japan). In this study red blood cell count (RBC [x106/μl]), white 
blood cell count (WBC [x103/μl]), monocyte-granulocyte ratio 
and platelet count (Plt [x103/μl]) were analyzed (anticoagulant: 
1.5 mg/ml K3-EDTA).
Blood coagulation time parameters, such as prothrombin 
time (PT [s]), activated partial thromboplastin time (APTT [s]), as 
well as fibrinogen concentration (Fbg [g/dl]) were determined by a 
Sysmex CA-500 automated coagulometer (TOA Medical Electronics 
Co. Ltd., Japan) (anticoagulant: 0.129 M sodium-citrate).
Red blood cell aggregation has been tested by 
two methods: the light-transmittance based Myrenne MA-1 
erythrocyte aggregometer (Myrenne GmbH, Germany) and the 
laser diffraction based LoRRca ektacytometer (Mechatronics BV, 
The Netherlands) (anticoagulant: 1.5 mg/ml K3-EDTA).
Histological investigation
On the 14th postoperative day under general anesthesia 
the grafts with intact vessel parts over the anastomoses and the 
contralateral, intact femoral arteries were excised. The specimens 
were fixed in 10% formalin before the regular dehydration and 
embedding protocol, and microtomed into 5 µm sections. Standard 
hematoxylin-eosin (H&E) staining, as well as immunohistochemistry 
for CD31 was carried out on the specimens.
Statistical analysis
Data are presented as means ± standard deviation (S.D.). 
Although the case number was low, for inter-group comparison 
student t-test or Mann-Whitney RS test were used, and one-way 
ANOVA tests (Dunn’s or Bonferroni method) were carried out for 
intra-group comparisons, depending on the data distribution, with 
a level of significance of p<0.05.
Results 
General postoperative observations
All experimental animals survived the operations and 
there was no death during the 2-week postoperative follow-up 
period. No surgical complication -neither early, nor late- was 
detected. The motion of the animals were normal during the 2-week 
follow-up period, there was no sign for hind limb circulatory 
problem. The skin temperature values of the non-operated and 
operated legs were identical (Figure 1).
Hematological parameters
Table 1 shows the blood cell count parameters. The red 
blood cell count slightly decreased over the 2-week follow-up 
period in the Control group (versus base values: p=0.002 on the 
1st, p=0.018 on the 7th and p=0.003 on the 14th postoperative day). 
The Grafted group showed the same tendency (versus base values: 
p=0.021 on the 3rd, p=0.033 on the 5th, p<0.001 on the 7th, and 
p=0.038 on the 14th day), and expressed moderately lower values 
compared to the Control group (p=0.046 on the 3rd, and p=0.049 on 
the 7th day). By the 7th day a definitive decrease in the red blood cell 
count was observed, being significant compared to the base values. 
FIGURE 1 – Relative values of skin temperature: right side (non-
operated limb) values to left side (operated limb) values measured at the 
end of the operation (End-op.) and during the postoperative follow-up 
period. Means ± S.D.
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Variable Group Base
Postoperative days
1st 3rd 5th 7th 14th
RBC 
[x106/μl]
Control
7.48 
± 0.67
6.68  
± 0.21 
*
7.24  
± 1.23
6.85  
± 0.68
6.52  
± 0.76 
*
6.28  
± 0.64 
*
Grafted
6.9  
± 0.45
6.49  
± 0.54
6.31  
± 0.62 
*#
6.28 
 ± 0.72 
*
5.85  
± 0.57 
*#
6.38  
± 0.58 
*
WBC 
[x103/μl]
Control
10.82  
± 1.49
14.67  
± 2.08 
*
12.91  
± 1.87
12.21  
± 2.37
13.48  
± 1.34 
*
11.2 
± 0.99
Grafted
11.41  
± 1.27
22.49 
± 5.34 
*#
15.46  
± 4.04 
*
14.68  
± 3.1 *
13.49  
± 2.13 
*
71.2  
± 2.8
Plt
[x103/μl]
Control
229.5  
± 39.7
229  
± 58.7
255  
± 70.5
300.1  
± 95.1
333.1  
± 
117.2
332.7 
± 
100.2
Grafted
284.9  
± 94.3
331.2  
± 152.7
400.7  
± 145.5 
#
391  
± 82.1 
*#
433.2  
± 77.8 
*
477.9 
± 74.4 
*#
TABLE 1 – Changes of red blood cell count (RBC), white blood 
cell count (WBC) and platelet count (Plt) in the Control and Grafted groups.
Means ± S.D., * p<0.05 vs. base;  # p<0.05 vs. Control
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White blood cell count (total leukocyte count) increased 
by the 1st postoperative day (p<0.001 in both groups), in a larger 
magnitude in the Grafted group (p=0.002 vs. Control). The 
cell count normalized in the Control group, but in the grafted it 
remained elevated until the end of the first postoperative week 
(compared to base: p=0.019 on the 3rd day, p=0.005 on the 5th 
day and p=0.016 on the 7th day.) The monocyte-granulocyte ratio 
remained between 60-70%, except for the 5th and 7th day, when the 
values were 81.73 ± 3.78 % and 74.3 ± 3.98 %, respectively.
Platelet count of the Grafted group continuously increased 
over the experimental period. The rise was significant from the 3rd 
postoperative day compared to the base values (5th day: p=0.015; 
7th day: p=0.001; 14th day: p<0.001) and versus the Control group, 
too (3rd day: p=0.03; 5th day: p=0.046; 14th day: p=0.003).
Blood coagulation parameters
Changes of selected blood coagulation parameters are 
shown in Table 2. Prothrombin time did not show important 
changes, however, activated partial thromboplastin time rose twice 
in the Grafted group: on the 3rd day (p=0.048 vs. base) and on the 
7th day (p=0.012 vs. base). Fibrinogen concentration rose by the 1st 
day and gradually decreased by the end of the follow-up period. 
Although it remained in physiological manner, there were significant 
differences (on the 1st day: p<0.001 vs. base and vs. Control; on the 
3rd day: p=0.023 vs. base and p=0.002 vs. Control; on the 5th day: 
p=0.043 vs. base and p=0.002 vs. Control).
Changes in erythrocyte aggregation
Table 3 presents the parameters tested by the LoRRca 
device. The aggregation index (AI [arbitrary unit]) represent the 
magnitude of aggregation over the tested 120-second period, the 
amplitude shows the heights of the syllectogram curve compared 
to the initial values (Amp [au]), while t1/2 [s] shows the time 
point when the aggregation process reaches the half of the total 
aggregation index values. AI values where moderately higher in the 
Grafted group on the 1st, 3rd and 5th postoperative day, together with 
increased Amp values (at the 7th day it was significant: p=0.008 vs. 
Control), while the t1/2 values alluded to a faster aggregation.
Variable Group Base
Postoperative days
1st 3rd 5th 7th 14th
PT 
[s]
Control
8.96  
± 0.15
8.3 
± 0.7
8.2 
± 0.88
7.37  
± 0.38
8.56 
± 1.49
7.33 
± 0.12 
*
Grafted
8.0  
± 1.18
7.37 
± 0.93 
#
7.74 
± 1.17
7.04 
 ± 0.73
7.81  
± 1.23
7.55  
± 0.47
APTT 
[s]
Control
10.51 
± 7.67
15.68 
± 
12.38
13.18  
± 9.75
9.77  
± 5.92
16.08 
± 9.61
17.11 
± 4.51
Grafted
9.18  
± 6.93
16.24 
± 9.82
22.12  
± 6.44 
*
16.72  
± 3.52
25.15  
± 10.89 
*
11.43  
± 5.1
Fbg
[g/dl]
Control
1.86  
± 0.08
2.18  
± 0.15
2.2  
± 0.85
1.97  
± 0.21
2.07  
± 0.25
2.07  
± 0.28
Grafted
2.1 
± 0.44
3.3  
± 0.37 
*#
2.87  
± 0.24 
*#
2.58 
± 0.32 
*#
2.47  
± 0.25
2.03 
± 0.21
Means ± S.D., * p<0.05 vs. base;  # p<0.05 vs. Control
TABLE 2 – Changes of prothrombin time (PT), activated 
partial thromboplastin time (APTT) and fibrinogen concentration (Fbg) in 
the Control and Grafted groups.
Variable Group Base
Postoperative days
1st 3rd 5th 7th 14th
AI
[au]
Control
51.35  
± 2.45
48.81 
± 9.68
50.11 
± 4.02
45.2 
± 11.34
49.49 
± 3.27
50.61 
± 5.49
Grafted
46.27  
± 
12.09
55.13 
± 
12.17
57.63 
± 5.57
52.21 
 ± 4.04
49.51  
± 8.12
48.38  
± 5.64
Amp 
[au]
Control
23.82 
± 2.62
20.13 
± 5.08
24.75  
± 2.61
23.71  
± 4.05
23.94 
± 1.57
23.28 
± 2.99
Grafted
28.71  
± 2.09
24.8 
± 5.17
29.65  
± 2.34
27.88  
± 2.07
30.42  
± 3.16 
#
25.08  
± 5.01
t1/2
[s]
Control
3.8  
± 0.4
4.46  
± 2.07
4.0  
± 0.71
3.92  
± 0.64
4.07  
± 0.64
3.97  
± 0.91
Grafted
4.11 
± 2.15
3.55  
± 2.05
2.92  
± 0.63
3.67 
± 0.62
4.26  
± 1.38
4.35 
± 1.03
TABLE 3 – Changes of red blood cell aggregation parameters 
aggregation index (AI), amplitude (Amp) and aggregation half-time (t1/2) 
tested by the LoRRca in blood samples of Control and Grafted groups.
Means ± S.D., # p<0.05 vs. Control
Erythrocyte aggregation index M 5 s and M 10 s values 
(tested with Myrenne aggregometer) represent the magnitude of 
the aggregation at the 5th and 10th second of the process measured 
at stasis. In the Grafted group these values showed significant 
increase during the 1st postoperative week, peaking on the 1st and 
3rd postoperative days (Figure 2). 
Toth C et al.
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The M 5 s values (at 5th second of the aggregation process) 
increased on the 1st (p=0.011 vs. base, p=0.03 vs. Control), 3rd 
(p<0.001 vs. base and vs. Control) 5th (p=0.021 vs. base) and 7th 
day (p<0.001 vs. base and vs. Control). The values of M 10 s (at 
10th second of the aggregation process) resulted in larger values 
and more prominent differences between the experimental groups 
(on the 1st day: p=0.029 vs. base; on the 3rd day: p<0.001 vs. base 
and vs. Control; on the 5th day: p=0.006 vs. base and p<0.001 vs., 
Control; and on the 7th day: p=0.006 vs. base).
Histological investigations 
On the 14th day during the biopsy taking, the diameter 
of the control-side femoral artery was 3.56 ± 0.13 mm, the graft’s 
one was 3.62 ± 0.17, while the artery segment just above the 
graft was 3.5 ± 0.41 mm, but below, it was 2.75 ± 0.28 mm in 
diameter (p<0.001 vs. graft, p=0.024 vs. above graft and p=0.016 
vs. control-side artery).
Histologically we found matured thrombus at the 
anastomoses narrowing the lumen. Imbedded capillary network 
lined with endothelium was observed in the fibrin web and 
connective tissue filled with various sized and shaped red blood 
cells. It seemed to be fixed to the inner side of the arterial 
intimal layer. At site of the proximal anastomoses the grafts were 
observed in the scared thickening of the adventitia. The fixture 
of thrombus inside the grafts was not obvious, here we could see 
“free” inner layer. Freshly formed thrombotic layers were seen 
towards the distal segment. At the site of the distal anastomoses 
we observed scar tissue with foreign body giant cells and mixed 
inflammatory cells around the surgical suture material in the 
adventitia, which was present as continuity along a short section 
of the graft (Figure 3).
FIGURE 3 – Representative histological photograph of the grafted vessel 
section, showing matured thrombus at the anastomoses narrowing the 
lumen (H&E staining, original magnification: x500).
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FIGURE 2 – Alterations of red blood cell aggregation index M 5 s (A) and M 10 s (B) values in the Control and Grafted groups. Means ± S.D., * 
p<0.05 vs. base;  # p<0.05 vs. Control
The widening of the internal elastic lamina was observed, but 
the endothelium lining was not always present. The observed thrombi 
seem to be the continuity of this widening. In the reticulate wall of 
the thrombi red blood cells and inflammatory cells were apparent. 
The endothelialization did not occur during the 2-week period, which 
was confirmed by the CD31 immunohistochemical examination. 
However, pseudointima formations made up from thrombotic 
elements are visible in certain segments. The arterial sections from 
the control side show regular, intact histological structure.
Discussion
Small-caliber vascular conduits are still an important 
tool in the surgical management of peripheral vascular diseases. 
However, the problem of early failure is a serious clinical 
problem9-11. Since not only the problem of small-caliber vascular 
conduits must be considered, but the question of biomechanical 
tissue remodeling is also a key factor with all the shear stress-, 
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stretching-, fluid biomechanical and mechanical micro-
environmental relations15,16. However, vascular tissue engineering 
provides a wide aspect for finding the possibly best solution for 
vessel substitutions15-17.
The healing of arterial graft is a complex and long 
process, depending on numberless factors, probably including 
inter-species differences, as well. Canine models may provide 
important information for vascular surgery research18-25. Kuzuya 
et al.22 investigated the healing process of ePTFE vascular access 
grafts (internal diameter: 5 mm, length: 15 cm) with various 
intermodal distances. They followed the process for 12 weeks. 
According to their findings, in 2 weeks the inflammatory phase 
almost ended and fibroblast proliferation was almost complete. 
Kasza et al.21 found that after peripheral arterial stent implantation 
the restitution of vascular wall was completed by the end of 
the first postoperative month. Hess et al.26 demonstrated that 
approximately six months is needed for a 5-cm polyurethane 
prosthesis for complete endothelialisation. It has also been shown 
that in a 6-9-cm PTFE graft only in about 60% endothelialisation 
occurs by the 12th postoperative month27. 
Clowes et al.27 in their baboon experiment used 4-mm 
PTFE grafts with 6-8 cm in length implanted into the common 
iliac artery. They found that by the end of the 1st postoperative 
week the luminal surface of the graft was covered by thrombus 
and some patches of endothelial cells. During the 2nd week the 
thrombus was replaced and by the 4th-12th week the grafts luminal 
surface was covered with cells resembling endothelium27.
Hess et al.28 used endothelial-cell-seeded or non-
seeded 3 mm wide, 5 cm long PTFE grafts in beagles, implanted 
into the femoral artery. The graft size and location were very 
similar to our experiment. Without anti-platelet therapy 
(acetylsalicylic acid or dipyridamole) in the 1st postoperative 
week 7 of 8 seeded prostheses were patent, while only 1 of 8 
non-seeded one was patent.
In this model we focused on the changes over the 
first two postoperative weeks providing a relatively frequent 
investigation protocol during the 1st postoperative week. 
We found that the majority of the blood coagulation and red 
blood cell aggregation changes happened during the 1st week. 
Previously we studied the effect of hind limb ischemia-
reperfusion on hematological and blood coagulation parameters, 
and we also saw the critical importance of 1stpostoperative 
week29. Inflammatory processes, acute phase reactions can be 
associated with alterations with hemorheological parameters, 
too30,31. We saw that fibrinogen concentration closed very 
quickly and the 2-peak elongation of coagulation time 
parameters with a continuously increasing platelet count might 
suggest that a thrombotic event could happen in the period of 
3rd - 7th postoperative day.
Failure of the graft can be due to complex reasons 
that include the hemodynamic effect of the small-caliber tube, 
the surface properties, activation of hemostatic cascades and 
mechanical damage of blood cells, among others9-14. Along with 
the injury of the intima, the inflammatory events induced by the 
sutures of the anastomoses may contribute to the development of 
thrombus. Here it may come into play that the vessels incidentally 
bend and refract above the graft after surgery while positioning 
the lower limb back into natural position and during the normal 
everyday movement of the animal. There were no sign of circulatory 
problems on the operated side, no change in the movement and 
behavior of the animal, and the skin temperatures were normal; 
it showed virtually similar values with the contralateral non-
operated side. The anastomoses originated from the gluteal region 
might compensate the circulation of the limb. 
Besides the general hematological and blood coagulation 
time parameters’ changes, we observed an early increase in 
erythrocyte aggregation values, too. Red blood cell aggregation is 
determined by cellular (cell morphology, deformability, membrane 
mechanical properties, composition of the surface glycocalyx) 
and plasmatic factors (e.g. fibrinogen concentration)30,32,33. 
Free radicals deliberating during ischemia-reperfusion and 
inflammatory processes, mechanical cell damage, changes in red 
blood cell deformability, alteration in fibrinogen concentration, as 
well as micro-environmental conditions (pH, osmorality), all may 
result in altered red blood cell aggregation30,31. Furthermore, the 
mechanical properties of the cell membrane also play an important 
role. In a separate paper we have analyzed the mechanical stability 
of the red blood cells using various stress conditions in a complex 
evaluation process34. An increase in erythrocyte aggregation 
may have local and even remote effect, too, since this parameter 
plays an important role in the rheology of the microcirculation. 
Increased red blood cell aggregation may cause numerous in 
vivo effects resulting in increased flow resistance, so contributing 
to disturbances of the tissue perfusion and modifying local 
hemodynamic profile35. 
Conclusions
The PTFE graft implantation for the replacement of the 
resected femoral arterial segment caused changes in the coagulation 
parameters and hemorheological properties, which lowered then 
equaled to the Control group by the end of the 2-week follow-up 
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period. Better clarifying the factors leading to early thrombosis of 
the small-caliber grafts is a very important issue. Further studies 
are needed for revealing the optimal conditions on geometry, 
length, position, hemodynamic and hemorheological factors, 
moving relations or even impregnated grafts that my decrease the 
chance for thrombus formation.
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